Sars Cov 2 Variants - Vaccines

Relevant Publications

Imprinting of IgA responses in previously infected individuals receiving bivalent mRNA vaccines (WT and BA.4/BA.5 or WT and BA.1).

Issue Release: 2024

SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.

Issue Release: 2024

Associations between COVID-19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS-CoV-2 variants.

Issue Release: 2024

UnCoVar: a reproducible and scalable workflow for transparent and robust virus variant calling and lineage assignment using SARS-CoV-2 as an example.

Issue Release: 2024

Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1.

Issue Release: 2024

Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice.

Issue Release: 2024

How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022.

Issue Release: 2024

An Outbreak of SARS-CoV-2 in Captive Armadillos Associated with Gamma Variant in Argentina.

Issue Release: 2024

The Malaria Box molecules: a source for targeting the RBD and NTD cryptic pocket of the spike glycoprotein in SARS-CoV-2.

Issue Release: 2024

Protocol for the creation and characterization of SARS-CoV-2 variant testing panels using remnant clinical samples for diagnostic assay testing.

Issue Release: 2024

Syndecan-1 as a prognostic biomarker in COVID-19 patients: a retrospective study of a Japanese cohort.

Issue Release: 2024

Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection.

Issue Release: 2024

Clinical performance of the Roche Cobas Liat SARS-CoV-2 & influenza A/B assay: A systematic review and meta-analysis.

Issue Release: 2024

Antibody drugs targeting SARS-CoV-2: Time for a rethink?

Issue Release: 2024

Molecular interactions of the Omicron, Kappa, and Delta SARS-CoV-2 spike proteins with quantum dots of graphene oxide.

Issue Release: 2024

Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study.

Issue Release: 2024

Detection of COVID-19 by quantitative analysis of carbonyl compounds in exhaled breath.

Issue Release: 2024

Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2.

Issue Release: 2024

Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants.

Issue Release: 2024

A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug.

Issue Release: 2024

How Can Blockchain Improve Vaccine Supply Chains?

How Can Technology Improve Vaccine Access?

What are the Recommendations for HBV DNA Testing?

What Vaccines are Included in the Schedule?

Are Vaccines Only Necessary for Children?

How is Informed Consent Obtained?

Can Acyclovir be used during Pregnancy?

Where Can You Get Vaccinated?

Who should not use Acyclovir?

How Can Individuals Contribute to the Initiative?

Partnered Content Networks

Relevant Topics